Delivery Order SPE2DB24D2109-SPE2DB25FHXFS

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,698.12 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The contract has an ultimate completion date of April 15, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,402.24, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,520.83 firm fixed price Delivery Order contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of July 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a ceiling value of $1,351.35 and a completion date of June 13, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,973.54 firm-fixed-price contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a completion date of January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,678.56 firm fixed-price contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award, valued at $1,233.82, is a delivery order contract for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The contract has a ceiling value of $1,233.82 and a completion date of April 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a ceiling value of $1,351.35 and runs through January 28, 2025. It is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,701.38, is a delivery order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a completion date of March 24, 2025 and is a firm fixed-price contract. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This is a federal contract award by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a ceiling value of $2,116.74. The contract is a Firm Fixed Price Delivery Order with a completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB25FHXFS
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a ceiling value of $1,814.88. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 18, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract award described is not designated as a set-aside.

Generated 9/16/25, 9:58 AM